Cite

HARVARD Citation

    Trum, N. et al. (2022). Mogamulizumab efficacy is underscored by its associated rash that mimics cutaneous T‐cell lymphoma: a retrospective single‐centre case series. British journal of dermatology. pp. 153-166. [Online]. 
  
Back to record